Interpharm Holdings Long Term Debt

As of the most recent data (December 2007), IPAH shows a long-term debt of $7.8M. That compares with $14M in the prior-year period — down 43.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IPAH's long-term debt is now $7.8M (was $14M) — a 43.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Interpharm Holdings is outperforming or lagging.

Tracking IPAH's long-term debt over time shows whether Interpharm Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $7.8M That compares with $14M in the prior-year period — down 43.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Interpharm Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $7.8M) with ownership activity and broader fundamentals.